Relief Therapeutics Holding AG (RLFTF)

[Vanilla Fitbit]

*** OUCH.... black and white****

As of July 31, 2021, Relief Therapeutics has not funded any costs of re-formulation of aviptadil into a shelf stable product. There is no provision in the Relief Agreement that gives Relief Therapeutics access to development assets that Relief Therapeutics has not funded, nor does Relief Therapeutics own any patents that block NRx’s development of ZYESAMI™.